Avalo Therapeutics, Inc. 10-Q filing
Filed 2025-11-06 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001534120-25-000018
- Form type
- 10-Q
- CIK
- 0001534120
- Primary document
- https://www.sec.gov/Archives/edgar/data/1534120/000153412025000018/avtx-20250930.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Avalo Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $0 | - | - |
| Operating Income | $-53.2M | - | - |
| Net Income | $-64.5M | - | - |
| Eps Basic | -5.47 | - | - |
| Eps Diluted | -5.47 | - | - |
| Cash And Equivalents | $27.0M | - | - |
| Total Assets | $125.1M | - | - |
| Total Liabilities | $33.6M | - | - |
| Shareholders Equity | $91.5M | - | - |
| Operating Cash Flow | $-37.2M | - | - |